Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)